J9153 HCPCS Level II code: Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
J9153 is the HCPCS code for “Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
Short description: Inj daunorubicin, cytarabine
HCPCS · United States
Medicare details
The indicators CMS publishes with J9153 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2019
Where J9153 sits
- 1J codesDrugs administered other than orally
- 2Active code J9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9153 mean?
J9153 is the HCPCS code for “Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9153?
CMS lists J9153’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9153
All J codesJ9120Injection, dactinomycin, 0.5 mgJ9130Dacarbazine, 100 mgJ9144Injection, daratumumab, 10 mg and hyaluronidase-fihjJ9145Injection, daratumumab, 10 mgJ9150Injection, daunorubicin, 10 mgJ9151Injection, daunorubicin citrate, liposomal formulation, 10 mgJ9155Injection, degarelix, 1 mgJ9160Injection, denileukin diftitox, 300 microgramsJ9161Injection, denileukin diftitox-cxdl, 1 mcgJ9165Injection, diethylstilbestrol diphosphate, 250 mgJ9171Injection, docetaxel, 1 mgJ9172Injection, docetaxel (docivyx), 1 mg